- Lobbying
- Lobbying by Amgen, Inc. FKA Horizon Therapeutics USA, Inc.
Lobbying Relationship
Bills mentioned
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
S.102: Prescription Drug Price Relief Act of 2019
Sponsor: Bernard Sanders (ID-Vt.)
S.102: West Los Angeles VA Campus Improvement Act of 2021
Sponsor: Dianne Feinstein (D-Calif.)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
S.102: Foster Care Stabilization Act of 2023
Sponsor: Deb Fischer (R-Neb.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Michaeleen Earle Crowell | Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders |
Martin Delgado | Staff Director, House Ag Approps; Professional Staff, MilCon/VA Approps, Budget Analyst APHIS Staff Director, House Ag Approps; Professional Staff, MilCon/VA Approps, Budget Analyst APHIS |
Kevin Casey | Senior Pol Dir, Dem Caucus; Counselor, Leg. Dir, Leg. Asst, Rep. Joseph Crowley; Staff Asst, Leg. Correspondent, Rep. Bob Weygand |
Olivia Kurtz (HOUSE ONLY) | Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle |
Olivia Kurtz | Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle |
Martin Reiser | Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate